Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P Piccini

Showing results (451-460 of 538) with videos related to

Pageof 54
Sort By:
Circulation. Cardiovascular Quality and Outcomes|May 17, 2019
Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life ScoreDaJuanicia N Holmes, Jonathan P Piccini, Larry A Allen, et al.
Journal of the American Heart Association|April 27, 2019
Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF RegistryAlexander C Perino, Peter Shrader, Mintu P Turakhia, et al.
Journal of the American College of Cardiology|February 9, 2013
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)Manesh R Patel, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Stroke|April 19, 2014
Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillationGraeme J Hankey, Susanna R Stevens, Jonathan P Piccini, et al.
Journal of the American Heart Association|March 10, 2016
Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AFSean D Pokorney, Jonathan P Piccini, Susanna R Stevens, et al.
Clinical Cardiology|August 19, 2023
Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registriesToon Wei Lim, Alan John Camm, Saverio Virdone, et al.
Clinical Cardiology|July 29, 2016
Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS TrialLarry R Jackson, Jonathan P Piccini, Derek D Cyr, et al.
Circulation. Arrhythmia and Electrophysiology|November 17, 2017
Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation)Adam S Barnett, Sunghee Kim, Gregg C Fonarow, et al.
Circulation|September 9, 2010
Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardiaDomenico Corrado, Hugh Calkins, Mark S Link, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 28, 2023
Detection of brain lesions after catheter ablation depends on imaging criteria: insights from AXAFA-AFNET 5 trialKarl Georg Haeusler, Felizitas A Eichner, Peter U Heuschmann, et al.
Pageof 54

Showing results (451-460 of 538) with videos related to

Sort By:
Pageof 54
Circulation. Cardiovascular Quality and Outcomes|May 17, 2019
Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life ScoreDaJuanicia N Holmes, Jonathan P Piccini, Larry A Allen, et al.
Journal of the American Heart Association|April 27, 2019
Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF RegistryAlexander C Perino, Peter Shrader, Mintu P Turakhia, et al.
Journal of the American College of Cardiology|February 9, 2013
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)Manesh R Patel, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Stroke|April 19, 2014
Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillationGraeme J Hankey, Susanna R Stevens, Jonathan P Piccini, et al.
Journal of the American Heart Association|March 10, 2016
Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AFSean D Pokorney, Jonathan P Piccini, Susanna R Stevens, et al.
Clinical Cardiology|August 19, 2023
Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registriesToon Wei Lim, Alan John Camm, Saverio Virdone, et al.
Clinical Cardiology|July 29, 2016
Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS TrialLarry R Jackson, Jonathan P Piccini, Derek D Cyr, et al.
Circulation. Arrhythmia and Electrophysiology|November 17, 2017
Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation)Adam S Barnett, Sunghee Kim, Gregg C Fonarow, et al.
Circulation|September 9, 2010
Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardiaDomenico Corrado, Hugh Calkins, Mark S Link, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 28, 2023
Detection of brain lesions after catheter ablation depends on imaging criteria: insights from AXAFA-AFNET 5 trialKarl Georg Haeusler, Felizitas A Eichner, Peter U Heuschmann, et al.
Pageof 54